APOE ε4 is also required in TREM2 R47H variant carriers for Alzheimer’s disease to develop

Advanced search
Browse by:

Department | Year

UCL Theses | Latest

Deposit your research

APOE ε4 is also required in TREM2 R47H variant carriers for Alzheimer’s disease to develop

Lashley, TC; Murray, CE; King, A; Troakes, C; Hodges, A; (2018) APOE ε4 is also required in TREM2 R47H variant carriers for Alzheimer’s disease to develop. Neuropathology and Applied Neurobiology 10.1111/nan.12474. Green open access

[thumbnail of Lashley_Murray-et-al-TREM2-APOE-scientific-correspondance-revised-CLEAN.pdf]

Preview

Text
Lashley_Murray-et-al-TREM2-APOE-scientific-correspondance-revised-CLEAN.pdf - Accepted Version
Download (394kB) | Preview

Type:	Article
Title:	APOE ε4 is also required in TREM2 R47H variant carriers for Alzheimer’s disease to develop
Open access status:	An open access version is available from UCL Discovery
DOI:	10.1111/nan.12474
Publisher version:	https://onlinelibrary.wiley.com/doi/abs/10.1111/na...
Language:	English
Additional information:	This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
UCL classification:	UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Clinical and Movement Neurosciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Neurodegenerative Diseases
URI:	https://discovery.ucl.ac.uk/id/eprint/10042220